1.
Bray, F, Ferlay, J, Soerjomataram, I, Siegel, RL, Torre, LA, Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
Google Scholar |
Crossref |
Medline2.
Smyth, EC, Nilsson, M, Grabsch, HI, van Grieken, NC, Lordick, F. Gastric cancer. Lancet. 2020;396:635-648.
Google Scholar |
Crossref |
Medline3.
Thrift, AP, El-Serag, HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534-542.
Google Scholar |
Crossref |
Medline4.
Al-Hajj, M, Wicha, MS, Benito-Hernandez, A, Morrison, SJ, Clarke, MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-3988.
Google Scholar |
Crossref |
Medline |
ISI5.
Lapidot, T, Sirard, C, Vormoor, J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645-648.
Google Scholar |
Crossref |
Medline |
ISI6.
Singh, SK, Clarke, ID, Hide, T, Dirks, PB. Cancer stem cells in nervous system tumors. Oncogene. 2004;23:7267-7273.
Google Scholar |
Crossref |
Medline |
ISI7.
Cheng, L, Alexander, R, Zhang, S, et al. The clinical and therapeutic implications of cancer stem cell biology. Expert Rev Anticancer Ther. 2011;11:1131-1143.
Google Scholar |
Crossref |
Medline8.
Al-Hajj, M, Becker, MW, Wicha, M, Weissman, I, Clarke, MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004;14:43-47.
Google Scholar |
Crossref |
Medline |
ISI9.
Valent, P, Bonnet, D, De Maria, R, et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012;12:767-775.
Google Scholar |
Crossref |
Medline |
ISI10.
Cazet, AS, Hui, MN, Elsworth, BL, et al. Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer. Nat Commun. 2018;9:2897.
Google Scholar |
Crossref |
Medline11.
De Jesus-Acosta, A, Sugar, EA, O’Dwyer, PJ, et al. Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma. Br J Cancer. 2020;122:498-505.
Google Scholar |
Crossref |
Medline12.
Cortes, JE, Heidel, FH, Hellmann, A, et al. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. Leukemia. 2019;33:379-389.
Google Scholar |
Crossref |
Medline13.
Morgensztern, D, Besse, B, Greillier, L, et al. Efficacy and safety of Rovalpituzumab Tesirine in third-line and beyond patients with DLL3-expressing, relapsed/refractory small-cell lung cancer: results from the phase II TRINITY study. Clin Cancer Res. 2019;25:6958-6966.
Google Scholar |
Crossref |
Medline14.
Goyal, L, Sirard, C, Schrag, M, et al. Phase I and biomarker study of the Wnt pathway modulator DKN-01 in combination with Gemcitabine/Cisplatin in Advanced Biliary tract cancer. Clin Cancer Res. 2020;26:6158-6167.
Google Scholar |
Crossref |
Medline15.
Matsuhashi, S, Manirujjaman, M, Hamajima, H, Ozaki, I. Control mechanisms of the tumor suppressor PDCD4: expression and functions. Int J Mol Sci. 2019;20:2304.
Google Scholar |
Crossref16.
Zhao, J, Xiao, A, Liu, C, et al. The HIF-1A/miR-17-5p/PDCD4 axis contributes to the tumor growth and metastasis of gastric cancer. Signal Transduct Target Ther. 2020;5:46.
Google Scholar |
Crossref |
Medline17.
Hwang, SK, Jeong, YJ, Chang, YC. PDCD4 inhibits lung tumorigenesis by the suppressing p62-Nrf2 signaling pathway and upregulating Keap1 expression. Am J Cancer Res. 2020;10:424-439.
Google Scholar |
Medline18.
Hu, L, Liang, Y, Wu, K, et al. Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells. Ann Transl Med. 2021;9:114.
Google Scholar |
Crossref |
Medline19.
Zhang, Y, Xiao, Y, Ma, Y, et al. ROS-mediated miR-21-5p regulates the proliferation and apoptosis of Cr(VI)-exposed L02 hepatocytes via targeting PDCD4. Ecotoxicol Environ Saf. 2020;191:110160.
Google Scholar |
Crossref |
Medline20.
Cmarik, JL, Min, H, Hegamyer, G, et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA. 1999;96:14037-14042.
Google Scholar |
Crossref |
Medline |
ISI21.
Wang, Q, Yang, HS. The role of Pdcd4 in tumour suppression and protein translation. Biol Cell. 2018;110:2018.
Google Scholar |
Crossref22.
Jin, X, Jeon, HY, Joo, KM, et al. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 2011;71:3066-3075.
Google Scholar |
Crossref |
Medline |
ISI23.
Yu, Y, Kanwar, SS, Patel, BB, et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis. 2012;33:68-76.
Google Scholar |
Crossref |
Medline |
ISI24.
Zhang, N, Duan, WD, Leng, JJ, et al. STAT3 regulates the migration and invasion of a stem-like subpopulation through microRNA-21 and multiple targets in hepatocellular carcinoma. Oncol Rep. 2015;33:1493-1498.
Google Scholar |
Crossref |
Medline25.
Hirata, K, Suzuki, H, Imaeda, H, et al. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. Br J Cancer. 2013;109:379-386.
Google Scholar |
Crossref |
Medline26.
Polyak, K, Weinberg, RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265-273.
Google Scholar |
Crossref |
Medline |
ISI27.
Medema, JP. Cancer stem cells: the challenges ahead. Nat Cell Biol. 2013;15:338-344.
Google Scholar |
Crossref |
Medline |
ISI28.
Zhu, Y, Liu, L, Hu, L, et al. Effect of Celastrus orbiculatus in inhibiting Helicobacter pylori induced inflammatory response by regulating epithelial mesenchymal transition and targeting miR-21/PDCD4 signaling pathway in gastric epithelial cells. BMC Complement Altern Med. 2019;19:91.
Google Scholar |
Crossref |
Medline29.
Zheng, W, Li, Y, Su, Z, Zhang, J, Shi, F, Liang, W. EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle. Exp Cell Res. 2021;402:112488.
Google Scholar |
Crossref |
Medline30.
Hu, Y, Wei, X, Lv, Y, et al. EIF3H interacts with PDCD4 enhancing lung adenocarcinoma cell metastasis. Am J Cancer Res. 2020;10:179-195.
Google Scholar |
Medline31.
Wang, X, Wang, H, Zhao, S, et al. Eukaryotic translation initiation factor EIF3H potentiates gastric carcinoma cell proliferation. Tissue Cell. 2018;53:23-29.
Google Scholar |
Crossref |
Medline32.
des Georges, A, Dhote, V, Kuhn, L, et al. Structure of mammalian eIF3 in the context of the 43S preinitiation complex. Nature. 2015;525:491-495.
Google Scholar |
Crossref |
Medline33.
Guo, X, Zhu, R, Luo, A, et al. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating snail stability. J Exp Clin Cancer Res. 2020;39:175.
Google Scholar |
Crossref |
Medline34.
Shen, Y, Chen, BL, Zhang, QX, Zheng, YZ, Fu, Q. Traditional uses, secondary metabolites, and pharmacology of Celastrus species - a review. J Ethnopharmacol. 2019;241:111934.
Google Scholar |
Crossref |
Medline35.
Chu, Z, Wang, H, Ni, T, et al. 28-Hydroxy-3-oxoolean-12-en-29-oic acid, a triterpene acid from Celastrus Orbiculatus extract, inhibits the migration and invasion of human gastric cancer cells in vitro. Molecules. 2019;24:2019.
Google Scholar |
Crossref36.
Wang, H, Gu, H, Feng, J, et al. Celastrus orbiculatus extract suppresses the epithelial-mesenchymal transition by mediating cytoskeleton rearrangement via inhibition of the Cofilin 1 signaling pathway in human gastric cancer. Oncol Lett. 2017;14:2926-2932.
Google Scholar |
Crossref |
Medline37.
Wang, H, Tao, L, Ni, T, et al. Anticancer efficacy of the ethyl acetate extract from the traditional Chinese medicine herb Celastrus orbiculatus against human gastric cancer. J Ethnopharmacol. 2017;205:147-157.
Google Scholar |
Crossref |
Medline38.
Zhu, Y, Liu, Y, Qian, Y, et al. Antimetastatic effects of Celastrus orbiculatus on human gastric adenocarcinoma by inhibiting epithelial-mesenchymal transition and NF-κB/snail signaling pathway. Integr Cancer Ther. 2015;14:271-281.
Google Scholar |
SAGE Journals |
ISI39.
Livak, KJ, Schmittgen, TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402-408.
Google Scholar |
Crossref |
Medline |
ISI40.
Long-Bao, W, Bo-Wen, Q, Yan-Xing, X. Establishment of human gastric cancer cell line (SGC-7901) intraperitoneally transplantable in nude mice. Recent Advances in Management of Digestive Cancers. Springer; 1993;416-418.
Google Scholar |
Crossref41.
Torre-Healy, LA, Berezovsky, A, Lathia, JD. Isolation, characterization, and expansion of cancer stem cells. Methods Mol Biol. 2017;1553:133-143.
Google Scholar |
Crossref |
Medline42.
Li, R, Wu, X, Wei, H, Tian, S. Characterization of side population cells isolated from the gastric cancer cell line SGC-7901. Oncol Lett. 2013;5:877-883.
Google Scholar |
Crossref |
Medline |
ISI43.
Zhang, S, Balch, C, Chan, MW, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68:4311-4320.
Google Scholar |
Crossref |
Medline |
ISI44.
Rappa, G, Mercapide, J, Anzanello, F, et al. Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp Cell Res. 2008;314:2110-2122.
Google Scholar |
Crossref |
Medline |
ISI45.
Brungs, D, Aghmesheh, M, Vine, KL, Becker, TM, Carolan, MG, Ranson, M. Gastric cancer stem cells: evidence, potential markers, and clinical implications. J Gastroenterol. 2016;51:313-326.
Google Scholar |
Crossref |
Medline46.
Jeyamani, L, Jayarajan, J, Leelakrishnan, V, Swaminathan, M. CagA and VacA genes of Helicobacter pylori and their clinical relevance. Indian J Pathol Microbiol. 2018;61:66-69.
Google Scholar |
Crossref |
Medline47.
Yu, H, Zeng, J, Liang, X, et al. Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer by downregulating programmed cell death protein 4 (PDCD4). PLoS One. 2014;9:e105306.
Google Scholar |
Crossref |
Medline48.
Sekar, D, Krishnan, R, Thirugnanasambantham, K, Rajasekaran, B, Islam, VI, Sekar, P. Significance of microRNA 21 in gastric cancer. Clin Res Hepatol Gastroenterol. 2016;40:538-545.
Google Scholar |
Crossref |
留言 (0)